logo

For the Inventor, By the Inventor

Darmstadt, Germany

Erich Schacht

This inventor holds 26 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gesellschaft MIT Beschraenkter Haftung, Celamerck Gmbh & Co. Kg. Active years: 1976-1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erich Schacht. Retrieved from https://idiyas.com/inventor/erich-schacht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26

% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 7

Forward Citations = 139(Granted Patents)


Location History:

  • Darmstadt, DE (1976 - 1980)
  • Seeheim, DE (1979 - 1981)
  • Seeheim-Jugenheim, DE (1981)

Company Filing History:

goldMedal23 out of 1,248 
 
Merck Patent Gesellschaft MIT Beschrankter Haftung
 patents
silverMedal2 out of 100 
 
Merck Patent Gesellschaft MIT Beschraenkter Haftung
 patents
bronzeMedal1 out of 31 
 
Celamerck Gmbh & Co. Kg
 patents

Years Active: 1976-1981

Loading Chart...
Areas of Expertise:
Benzothiazole Derivatives
Phenoxyacetic Acids
Anti-Inflammatory Compounds
Cholesterol Lowering
Quinolone Derivatives
Alkyne Compounds
Morpholino Compounds
Diphenoxyacetic Acids
Phenylbutanol Derivatives
Indole Derivatives
Araliphatic Dihalogen Compounds
Pyrazolidinones
26 patents (USPTO):Explore Patents
1. 4294839 - Benzothiazole derivatives and pharmaceutical formulations containing them (1981-10-13),
2. 4289774 - Lipid lowering and anti-thrombotic 6-arylpyridazin-3-ones and a process (1981-09-15),
3. 4239759 - Morpholino containing compounds, compositions and use thereof (1980-12-16),
4. 4196215 - Alkyne compounds and method of use (1980-04-01),
5. 4169720 - 2-[4-(4-Chlorophenoxymethyl)-phenoxy]-propionic acid compounds as (1979-10-02),
6. 4168312 - Quinolone derivatives (1979-09-18),
7. 4151302 - Araliphatic dihalogen compounds composition and method of use (1979-04-24),
8. 4151294 - Alkynols and process for their preparation (1979-04-24),
9. 4136200 - Phenylbutanol derivatives, processes for their preparation and (1979-01-23),
10. 4115456 - Alkyne compounds and method of use (1978-09-19),
11. 4110447 - Anti-inflammatory (halo-4-biphenylyl)-alkanolamines (1978-08-29),
12. 4072754 - Hydratropic acid derivatives and process for the production thereof (1978-02-07),
13. 4070461 - Biphenylyl ethers (1978-01-24),
14. 4069338 - Indole derivatives and process for their preparation (1978-01-17),
15. 4060633 - Phenylalkanol nitriles (1977-11-29),

Title: **Erich Schacht: A Pioneer in Pharmaceutical Innovations**

Introduction

Erich Schacht, based in Darmstadt, Germany, is an accomplished inventor recognized for his significant contributions to the pharmaceutical field. He holds an impressive portfolio of 26 patents, showcasing his innovative work in drug development and formulations.

Latest Patents

Schacht's recent patents include groundbreaking work on benzothiazole derivatives and pharmaceutical formulations designed to enhance therapeutic efficacy. One such patent describes benzothiazole derivatives characterized by specific molecular structures, offering potential benefits in various medicinal applications. Another notable invention focuses on lipid-lowering and anti-thrombotic compounds known as 6-arylpyridazin-3-ones, which exhibit valuable pharmacological properties, including the ability to lower lipid levels and provide anti-thrombotic effects.

Career Highlights

Throughout his career, Erich Schacht has made substantial contributions while working for leading companies in the pharmaceutical industry. He has been associated with Merck Patent Gesellschaft mit beschränkter Haftung, where he applied his expertise to develop innovative pharmaceutical solutions.

Collaborations

Schacht has collaborated with esteemed coworkers, including Werner Mehrhof and Zdenek Simane, fostering a team environment that has led to the advancement of novel pharmaceutical innovations. These partnerships reflect his commitment to research and development in the pursuit of effective medical treatments.

Conclusion

Erich Schacht's dedication to innovation in the pharmaceutical realm is evident through his extensive patent portfolio and collaborative efforts. His work not only contributes to the advancement of drug formulations but also highlights the impact of inventive thinking in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…